检索范围:
排序: 展示方式:
Nanocrystal technology for drug formulation and delivery
Tzu-Lan CHANG, Honglei ZHAN, Danni LIANG, Jun F. LIANG
《化学科学与工程前沿(英文)》 2015年 第9卷 第1期 页码 1-14 doi: 10.1007/s11705-015-1509-3
关键词: drug nanocrystal nanotechnology formulation bioavailability stabilizers drug delivery
Photocatalytic degradation of the acetaminophen by nanocrystal-engineered TiO
Reza Katal, Mohammad Tanhaei, Jiangyong Hu
《环境科学与工程前沿(英文)》 2021年 第15卷 第2期 doi: 10.1007/s11783-020-1319-9
《化学科学与工程前沿(英文)》 2023年 第17卷 第7期 页码 853-866 doi: 10.1007/s11705-022-2256-x
关键词: chitosan foam cellulose nanocrystals acid red 134 adsorption
Taking advantage of drug resistance, a new approach in the war on cancer
null
《医学前沿(英文)》 2018年 第12卷 第4期 页码 490-495 doi: 10.1007/s11684-018-0647-7
Identification of the driver mutations in cancer has resulted in the development of a new category of molecularly targeted anti-cancer drugs. However, as was the case with conventional chemotherapies, the effectiveness of these drugs is limited by the emergence of drug-resistant variants. While most cancer therapies are given in combinations that are designed to avoid drug resistance, we discuss here therapeutic approaches that take advantage of the changes in cancer cells that arise upon development of drug resistance. This approach is based on notion that drug resistance comes at a fitness cost to the cancer cell that can be exploited for therapeutic benefit. We discuss the development of sequential drug therapies in which the first therapy is not given with curative intent, but to induce a major new sensitivity that can be targeted with a second drug that selectively targets the acquired vulnerability. This concept of collateral sensitivity has hitherto not been used on a large scale in the clinic and holds great promise for future cancer therapy.
关键词: cancer drug resistance genetic screens senescence targeted therapy
Biodegradable polymethacrylic acid grafted psyllium for controlled drug delivery systems
Ranvijay KUMAR, Kaushlendra SHARMA
《化学科学与工程前沿(英文)》 2013年 第7卷 第1期 页码 116-122 doi: 10.1007/s11705-013-1310-0
关键词: psyllium acetyl salicylic acid in-vitro drug release swelling biodegradation
Protein microspheres for pulmonary drug delivery
Yongda SUN,
《化学科学与工程前沿(英文)》 2010年 第4卷 第1期 页码 82-86 doi: 10.1007/s11705-009-0307-1
关键词: advanced engineering improved pressure aqueous technique
Semi-solid materials for controlled release drug formulation: current status and future prospects
Michelle TRAN,Chun WANG
《化学科学与工程前沿(英文)》 2014年 第8卷 第2期 页码 225-232 doi: 10.1007/s11705-014-1429-7
关键词: controlled release drug delivery semi-solids polymer excipient
Xiaojing ZHANG, Weixin ZHANG, Zeheng YANG, Zhao ZHANG
《化学科学与工程前沿(英文)》 2012年 第6卷 第3期 页码 246-252 doi: 10.1007/s11705-012-1299-9
Prevalence of antifolate drug resistance markers in in China
《医学前沿(英文)》 2022年 第16卷 第1期 页码 83-92 doi: 10.1007/s11684-021-0894-x
关键词: drug resistance antifolates molecular markers Plasmodium vivax China
Clinical analysis of 275 cases of acute drug-induced liver disease
LI Lei, JIANG Wei, WANG Jiyao
《医学前沿(英文)》 2007年 第1卷 第1期 页码 58-61 doi: 10.1007/s11684-007-0012-8
Zhijian CHEN, Wei LI,
《化学科学与工程前沿(英文)》 2010年 第4卷 第1期 页码 1-1 doi: 10.1007/s11705-009-0306-2
Bioorthogonal chemistry based on-demand drug delivery system in cancer therapy
《化学科学与工程前沿(英文)》 2023年 第17卷 第4期 页码 483-489 doi: 10.1007/s11705-022-2227-2
关键词: bioorthogonal reaction cancer therapy metabolic glycoengineering bioorthogonal catalytic patch
Engineering platelet-mimicking drug delivery vehicles
Quanyin Hu, Hunter N. Bomba, Zhen Gu
《化学科学与工程前沿(英文)》 2017年 第11卷 第4期 页码 624-632 doi: 10.1007/s11705-017-1614-6
关键词: drug delivery platelets nanomedicine bio-inspired biomimetic
Detection of AmpC β-lactamase and drug resistance of
Rong WANG, Shangwei WU, Xue LI, Ping HE, Yunde LIU
《医学前沿(英文)》 2009年 第3卷 第1期 页码 72-75 doi: 10.1007/s11684-009-0004-y
Role of the forkhead transcription factor FOXO-FOXM1 axis in cancer and drug resistance
null
《医学前沿(英文)》 2012年 第6卷 第4期 页码 376-380 doi: 10.1007/s11684-012-0228-0
The forkhead transcription factors FOXO and FOXM1 have pivotal roles in tumorigenesis and in mediating chemotherapy sensitivity and resistance. Recent research shows that the forkhead transcription factor FOXM1 is a direct transcriptional target repressed by the forkhead protein FOXO3a, a vital downstream effector of the PI3K-AKT-FOXO signaling pathway. Intriguingly, FOXM1 and FOXO3a also compete for binding to the same gene targets, which have a role in chemotherapeutic drug action and sensitivity. An understanding of the role and regulation of the FOXO-FOXM1 axis will impact directly on our knowledge of chemotherapeutic drug action and resistance in patients, and provide new insights into the design of novel therapeutic strategy and reliable biomarkers for prediction of drug sensitivity.
关键词: FOXO3a FOXM1 transcription factor cancer drug resistance tumorigenesis
标题 作者 时间 类型 操作
Nanocrystal technology for drug formulation and delivery
Tzu-Lan CHANG, Honglei ZHAN, Danni LIANG, Jun F. LIANG
期刊论文
Photocatalytic degradation of the acetaminophen by nanocrystal-engineered TiO
Reza Katal, Mohammad Tanhaei, Jiangyong Hu
期刊论文
Dialdehyde cellulose nanocrystal cross-linked chitosan foam with high adsorption capacity for removal
期刊论文
Biodegradable polymethacrylic acid grafted psyllium for controlled drug delivery systems
Ranvijay KUMAR, Kaushlendra SHARMA
期刊论文
Semi-solid materials for controlled release drug formulation: current status and future prospects
Michelle TRAN,Chun WANG
期刊论文
Nanostructured hollow spheres of hydroxyapatite: preparation and potential application in drug delivery
Xiaojing ZHANG, Weixin ZHANG, Zeheng YANG, Zhao ZHANG
期刊论文
Clinical analysis of 275 cases of acute drug-induced liver disease
LI Lei, JIANG Wei, WANG Jiyao
期刊论文
Introduction to the special issue of the 2009 International Symposium on Crystal Engineering & Drug Delivery
Zhijian CHEN, Wei LI,
期刊论文
Detection of AmpC β-lactamase and drug resistance of
Rong WANG, Shangwei WU, Xue LI, Ping HE, Yunde LIU
期刊论文